It seems to many that leukemia is tantamount to incurable disease and, when it occurs, it is as if it has been sentenced to death. But, actually, that’s not accurate. Let’s talk about leukemia today.
Leukemia, commonly known as the transformation of stem blood cells in our bodies, has become uncontrolled, and a large number of abnormally white cells, such as blood cells, have been created, thus affecting normal blood-making functions and other functions of the body. Depending on the maturity of leukaemia cells and their natural course, it can be divided into two broad categories, acute leukaemia and chronic leukaemia, with several different types broken down in each.
Acute leukaemia
In the past, acute leukaemia was indeed very dangerous because of its acute condition and rapid progress, with many patients likely to suffer from severe conditions such as anaemia, infection and haemorrhage in a short period of time, and very low rates of cure at a time of limited medical conditions.
But with the rapid development of medicine, the situation has changed so much! For acute lymphocyte leukaemia, which is common in children, a significant proportion of children can reach a clinical cure through a regulated chemotherapy programme. Clinically speaking, the clinical cure is that, after treatment, the patient can live as a healthy person and does not relapse for five years or more. Moreover, if chemotherapy is not working optimally, consideration could be given to stem blood cell transplants, giving patients more hope for healing.
There are also a number of effective treatments for such types as acute melody leukaemia among adults. New chemotherapy drugs are emerging, and doctors can develop individualized chemotherapy programmes based on the patient ‘ s specific leukaemia stratification, physical condition, etc., to improve the effectiveness of treatment. Support for treatment, such as the timely prevention of infection, blood transfusions, etc., helps patients to overcome the difficulties of chemotherapy and many are able to survive.
Chronic leukaemia
Chronic leukaemia has been relatively moderate and progressing less rapidly. Like chronic pyrocellular leukemia, who had a relatively short life span, there is now a target-oriented drug known as the chesamate inhibitor, with most patients taking their medications on time and regularly monitored, well under control and with little impact on their quality of life, which has been significantly extended, with some of them living for more than a decade or decades.
The same applies to chronic lymphocytal leukaemia, which, although difficult to cure at all, can stabilize and slow the progress of the disease through reasonable treatment, as well as to maintain a good living for a long time.
Factors affecting the effectiveness of leukaemia treatment
Of course, the efficacy of leukemia does not depend solely on the type of disease. The age of the patient, the underlying condition of the body and the combination of other diseases are also crucial. For example, young people, better-healthed people who do not have other serious basic diseases tend to be more resilient to various kinds of treatment and have a relatively better effect.
Moreover, the normative and dependent nature of treatment is particularly important. If patients are not treated on time and reviewed on a regular basis in accordance with the doctor’s programme, they may be delayed even if there is a good chance of cure.
So leukemia is not all incurable. As medicine progresses, more and more people with leukaemia can overcome the disease through scientific treatment, careful care and a positive mentality, or return to normal life through long-term “peaceful coexistence” with the disease. Don’t be desperate when you hear leukemia, believe in the power of modern medicine!
